Medtronic said its relationship with Nutrino's FoodPrint will leverage food data analytics across its diabetes portfolio.
FDA granted a de novo request for DreaMed Diabetes' Advisor Pro, an AI-based diabetes treatment decision support software.
Coming fresh off an IDE approval by FDA, Beta Bionics is set to integrate Senseonics’ Eversense CGM into the artificial intelligence-powered Bionic Pancreas.
Designers of wearable health devices will walk the catwalk at MD&M East to showcase the products that are enabling new capabilities in mobile healthcare, with a focus on prevention, screening, and disease management.
Bluetooth technology may be the gold standard in connected health, but what about the pitfalls? One diabetes management company argues that cell-enabled technology is the way to go.
ThinkGenetic’s co-founder and CEO is set to moderate panel at MD&M East and discuss how artificial intelligence is growing in healthcare and helping to redefine the medtech space.
FDA is calling on innovators to develop medical devices, digital health technologies, and diagnostic tests capable of addressing the opioid epidemic.
Ava, a startup, has raised about $30 million in a series B round to expand its bracelet-like technology into other aspects of health in women.
Beta Bionics receives IDE approval from FDA to begin a clinical trial testing the iLet Bionic Pancreas System.
An industry expert talks about the dramatic impact that artificial intelligence (AI) is having on the medical device field.
Itamar Medical developed the SleePath to help electrophysiologists assess patients' sleep apnea status and CPAP compliance and correlate that data to the patient's atrial fibrillation manifestations to achieve optimal outcomes after catheter ablation.
Murj has raised $8.5 million in a series B round to help increase marketing and sales efforts for its ICD data-monitoring solution.
Qure.ai is the next company in line to develop an AI-based technology that can help spot trauma in a patient’s CT scan.